![Assay: Irreversible inhibition of rat brain cytosolic MAGL assessed as [3H] - EMBL-EBI](https://cedclinic.com/wp-content/uploads/2026/06/ced-pexels-4226264-1-150x150.jpg "Assay: Irreversible inhibition of rat brain cytosolic MAGL assessed as [3H] - EMBL-EBI 6")
General Purpose AI Models Beat Clinical AI Tools in Medical Study
A comprehensive study published in Nature Medicine found that general purpose AI models consistently outperformed specialized clinical AI tools across multiple medical benchmarks. The research evaluated GPT-5.2, Gemini 3.1 Pro, and Claude Opus against…
What Survives After the Information Is Gone?
Framework preservation is the effort to preserve a useful way of thinking, not just the information that originally introduced it. This essay explores how AI Projects can help capture questions, assumptions, examples, cautions, and reasoning habits that…
A Cannabis-Based Medicine Goes Head-to-Head With Lorazepam for Sleep
A cannabis insomnia randomized trial published in 2026 compared a traditional cannabis-based herbal medicine with lorazepam for chronic insomnia. Both groups experienced substantial improvements in sleep quality, quality of life, and stress scores over…
Cannabis Oil for Fibromyalgia: New RCT Results Explained
A new Australian randomized, double-blind, placebo-controlled pilot trial found that a nightly 1:1 THC:CBD cannabis oil produced clinically meaningful pain relief in 70% of fibromyalgia patients, with large effect sizes for sleep quality and fibromyalgia…
Why THC Feels More Predictable When Inhaled Than Eaten
Inhaled vs oral THC effects were compared in a systematic review and dose-response meta-analysis of 41 placebo-controlled trials involving 1,020 participants. Researchers found that inhaled THC showed a measurable relationship between dose and subjective…
Cannabis Reduces Tics in Tourette Syndrome: 306 Patients
Dr. Benjamin Caplan, MD | Board-Certified Family Physician & Cannabis Medicine Specialist | Cannabis Science | June 5, 2026 Clinical Insight A meta-analysis of eight clinical studies and 306 adult patients found that cannabis-based medicines produced…
CBD for Severe Autism: What a 27-Month Study Found
A new long-term observational study published in Pharmacology Biochemistry and Behavior followed children with severe autism spectrum disorder on purified CBD for an average of 27.6 months. Improvements seen at three months were maintained, and 40% of…
FDA Grants Cannabis Extract VER-01 Breakthrough Therapy Status for Pain
The FDA has awarded Breakthrough Therapy Designation to VER-01, a pharmaceutical-grade cannabis extract for chronic low back pain. This marks the first FDA breakthrough therapy cannabis designation for pain treatment, backed by Phase 3 trials showing…
What a Large 2026 Study Reveals About GLP-1 Medications and Hair Loss
Semaglutide hair loss risk emerged as a significant signal in a large propensity-matched cohort study involving hundreds of thousands of patients. Researchers found higher rates of nonscarring hair loss among semaglutide and tirzepatide users compared…
GLP-1 Drugs, Semaglutide, and the Future of Alcohol Addiction Treatment
GLP-1 receptor agonists for alcohol use disorder are attracting growing scientific interest as potential tools for reducing alcohol consumption and relapse risk. This review examines preclinical evidence, observational studies, and randomized controlled…